- CollaborationsAACollaborations
Collaborations
DGx is working closely with thought leaders, large MS clinics and philanthropic organizations actively involved and committed to MS patient care, healthcare research and patient advocacy. We have included links to these organizations below for your convenience. Critical to DGx' accelerated development within its molecular diagnostic programs is its network of existing relationships with key medical practices in each of these clinical disciplines. These relationships are disease-centric partnerships which leverage the clinical experience and practice of key collaborators to:
• Identify appropriate disease targets with large market potential;
• Participate in the design of clinical studies;
• Assist in identification of key opinion leaders in the area;
• Provide critical patient samples for analysis;
• Assist in the identification and validation of marker sets; and
• Act as alpha- and beta-test sites for DGx’s molecular diagnostic assays.
DGx retains all commercial rights to the resulting molecular diagnostics products while sharing in a more robust understanding of disease biology with its collaborators, allowing for publications and grant work that is an off-shoot of our diagnostic programs.
Links to External Pages
